PET Imaging in Parkinson Disease Dementia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Washington University School of Medicine.
Recruitment status was  Recruiting
Information provided by:
Washington University School of Medicine Identifier:
First received: January 15, 2010
Last updated: March 2, 2011
Last verified: March 2011
The purpose of this study is to use a brain imaging method called PIB PET to determine dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.

Parkinson's Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Use of PIB PET Imaging to Evaluate Dementia Subtypes in Patients With Parkinson Disease

Resource links provided by NLM:

Further study details as provided by Washington University School of Medicine:

Biospecimen Retention:   Samples With DNA
whole blood

Estimated Enrollment: 125
Study Start Date: August 2006
Parkinson disease
individuals with Parkinson disease
healthy control
individuals without Parkinson disease


Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Participants with and without Parkinson disease will be recruited from the Movement Disorders Center at Washington University, the St. Louis metro area, and throughout the midwest region.

Inclusion Criteria:

  • PD patients must exhibit three of the following cardinal signs: rest tremor, rigidity, bradykinesia, or postural instability; or two of these features with one of the first three displaying asymmetry.

Exclusion Criteria:

  • history of head trauma, major neurological or psychiatric diseases other than Parkinson disease and dementia, e.g. stroke, multiple sclerosis, depression or schizophrenia
  • severe systemic diseases
  • inability to lie still for 90 minutes
  • metallic implants, pacemakers, or any other contraindication to MRI
  • refusal to consent to brain donation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01052350

Contact: Johanna Hartlein, MSN, APN 314-362-0420

United States, Missouri
NeuroClinical Research Unit (NCRU), Washington University School of Medicine Recruiting
St. Louis, Missouri, United States, 63110
Contact: Johanna Hartlein, MSN, APN    314-362-0240   
Sponsors and Collaborators
Washington University School of Medicine
Principal Investigator: Joel S. Perlmutter, MD Washington University School of Medicine
  More Information

No publications provided

Responsible Party: Joel S. Perlmutter, Washington University School of Medicine Identifier: NCT01052350     History of Changes
Other Study ID Numbers: 06-0706
Study First Received: January 15, 2010
Last Updated: March 2, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:
Parkinson disease
PET imaging

Additional relevant MeSH terms:
Parkinson Disease
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders processed this record on November 30, 2015